Mechanisms underlying progressive polyuria in familial neurohypophysial diabetes insipidus

Journal of Neuroendocrinology

Volumn 22, Issue 7, 2010, Pages 754-757

  Arima, H ^a   Oiso, Y ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Arginine vasopressin; Diabetes insipidus; Endoplasmic reticulum; Hereditary disease; Inclusion bodies

Indexed keywords

ARGIPRESSIN; GLYCOPROTEIN; HORMONE PRECURSOR; MESSENGER RNA; NEUROPHYSIN; NEUROPHYSIN II; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

BLOOD PRESSURE; BLOOD VOLUME; CELL ACTIVITY; CELL DEATH; CELL INCLUSION; CELL VIABILITY; DEHYDRATION; DIABETES INSIPIDUS; DIMERIZATION; DISEASE COURSE; DISULFIDE BOND; ELECTRON MICROSCOPY; FAMILIAL DISEASE; FLUID INTAKE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GLYCATION; GOLGI COMPLEX; GRANULOMA; HIGH SODIUM INTAKE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFECTION; MORPHOLOGY; NEOPLASM; NERVE CELL; NERVE FIBER TRANSPORT; NEUROHYPOPHYSIS; NONHUMAN; OSMOREGULATION; PLASMA OSMOLALITY; POLYURIA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; RIBOSOME; ROUGH ENDOPLASMIC RETICULUM; SODIUM RESTRICTION; SUPRAOPTIC NUCLEUS; TRANSGENIC RAT; URINE OSMOLALITY; URINE VOLUME; ANIMAL; CYTOLOGY; ENDOPLASMIC RETICULUM; GENETICS; METABOLISM; MUTATION; NEUROGENIC DIABETES INSIPIDUS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ARGININE VASOPRESSIN; CELL DEATH; DIABETES INSIPIDUS, NEUROGENIC; ENDOPLASMIC RETICULUM; HUMANS; INCLUSION BODIES; MUTATION; NEURONS; NEUROPHYSINS; POLYURIA; SUPRAOPTIC NUCLEUS;

EID: 77954168616     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2010.02028.x     Document Type: Review

References (19)

1. Robertson GL. Posterior pituitary. Endocrinology and Metabolism 1995, 385-432. Felig PBaxter JDFrohman LA. eds, New York, NY, McGraw-Hill
2. Burbach JP, Luckman SM, Murphy D, Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 2001, 81:1197-1267.
3. Acher R, Chauvet J, Rouille Y. Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial prehormones during intraneuronal secretory transport. J Mol Neurosci 2002, 18:223-228.
4. Arima H, Kondo K, Kakiya S, Nagasaki H, Yokoi H, Yambe Y, Murase T, Iwasaki Y, Oiso Y. Rapid and sensitive vasopressin heteronuclear RNA responses to changes in plasma osmolality. J Neuroendocrinol 1999, 11:337-341.
5. Kakiya S, Arima H, Yokoi H, Murase T, Yambe Y, Oiso Y. Effects of acute hypotensive stimulli on arginine vasopressin gene transcription in the rat hypothalamus. Am J Physiol Endocrinol Metab 2000, 279:E886-E892.
6. Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci 2008, 9:519-531.
7. Richard D, Bourque CW. Synaptic activation of rat supraoptic neurons by osmotic stimulation of the organum vasculosum lamina terminalis. Neuroendocrinology 1992, 55:609-611.
8. Christensen JH, Rittig S. Familial neurohypophyseal diabetes insipidus - an update. Semin Nephrol 2006, 26:209-223.
9. Ito M, Jameson JL, Ito M. Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J Clin Invest 1997, 99:1897-1905.
10. Ito M, Yu RN, Jameson JL. Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J Biol Chem 1999, 274:9029-9037.
11. Siggaard C, Rittig S, Corydon TJ, Andreasen PH, Jensen TG, Andresen BS, Robertson GL, Gregersen N, Bolund L, Pedersen EB. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. J Clin Endocrinol Metab 1999, 84:2933-2941.
12. Nijenhuis M, Zalm R, Burbach JP. Mutations in the vasopressin prohormone involved in diabetes insipidus impair endoplasmic reticulum export but not sorting. J Biol Chem 1999, 274:21200-21208.
13. Si-Hoe SL, De Bree FM, Nijenhuis M, Davies JE, Howell LM, Tinley H, Waller SJ, Zeng Q, Zalm R, Sonnemans M, Van Leeuwen FW, Burbach JP, Murphy D. Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. FASEB J 2000, 14:1680-1684.
14. Russell TA, Ito M, Ito M, Yu RN, Martinson FA, Weiss J, Jameson JL. A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. J Clin Invest 2003, 112:1697-1706.
15. Hayashi M, Arima H, Ozaki N, Morishita Y, Hiroi M, Ozaki N, Nagasaki H, Kinoshita N, Ueda M, Shiota A, Oiso Y. Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1641-R1649.
16. Nagasaki H, Ito M, Yuasa H, Saito H, Fukase M, Hamada K, Ishikawa E, Katakami H, Oiso Y. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. J Clin Endocrinol Metab 1995, 80:1352-1356.
17. Zeng Q, Carter DA, Murphy D. Cell specific expression of a vasopressin transgene in rats. J Neuroendocrinol 1994, 6:469-477.
18. Waller S, Fairhall KM, Xu J, Robinsion IC, Murphy D. Neurohypophyseal and fluid homeostasis in transgenic rats expressing a tagged rat vasopressin prepropeptide in hypothalamic neurons. Endocrinology 1996, 137:5068-5077.
19. Hiroi M, Morishita Y, Hayashi M, Ozaki N, Sugimura Y, Nagasaki H, Shiota A, Oiso Y, Arima H. Activation of vasopressin neurons leads to phenotype progression in a mouse model for familial neurohypophysial diabetes insipidus. Am J Physiol Regul Integr Comp Physiol 2010, 298:R486-R493.